Mitral valve regurgitation, the leakage of blood back to the left atrium during systole, is a significant cause of morbidity and mortality. The current treatment options for symptomatic mitral regurgitation are mitral valve repair and replacement. However, the operative mortality for both of these treatments remains substantial (1). Furthermore, these treatments are often not referred for elderly patients with comorbidities. Thus, there is a pressing need for less invasive, non-surgical treatments of mitral regurgitation.
- Bioengineering Division
Biomechanical Properties of Human Coronary Sinus for Minimally Invasive Mitral Valve Repair
- Views Icon Views
- Share Icon Share
- Search Site
Pham, T, & Sun, W. "Biomechanical Properties of Human Coronary Sinus for Minimally Invasive Mitral Valve Repair." Proceedings of the ASME 2010 Summer Bioengineering Conference. ASME 2010 Summer Bioengineering Conference, Parts A and B. Naples, Florida, USA. June 16–19, 2010. pp. 939-940. ASME. https://doi.org/10.1115/SBC2010-19638
Download citation file: